Home » Innovation and beauty » Aastrom secures US patent for autologous cell therapy product Aastrom Biosciences.

We are delighted that the U.S. Patent workplace recognizes this cell mixture to be exclusive to Aastrom now. In October 2010, the company announced that its prepared Phase 3 clinical plan in CLI received Fast Track designation by the U.S. Drug and Food Administration. The business also submitted papers to the FDA to get special protocol assessments for the scheduled program. Aastrom now has 26 U.S. And 36 international patents within the composition, production and usage of mixed-cell products.. Aastrom secures US patent for autologous cell therapy product Aastrom Biosciences, Inc., a leading developer of expanded autologous cellular treatments for severe, chronic cardiovascular diseases, today announced that it has been granted a U.S.The Press Center could have wireless Internet access, telephones, computers, photocopy and fax services, and refreshments. Free press registration for the meeting is open still.

Agilent Systems launches two Greenhouse Gases Analyzers Agilent Technology Inc. today announced the availability of two Greenhouse Gases Analyzers for simultaneous evaluation of methane , carbon dioxide , and nitrous oxide in air flow samples. The analyzers also can be used for soil gas plant or analysis breathing research, where the samples consist of CH4, N2O, and CO2. Both analyzers quickly can be expanded to determine sulfur hexafluoride . This analyzer is certainly configured with a multi-valve, micro-ECD, methanizer-FID mixture, achieving simultaneous analysis of greenhouse gases in one injection.